Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma.

a Charité Universitätsmedizin, Campus Virchow-Klinikum, Department of Hepatology and Gastroenterology, Berlin , Germany; b Hôpital Beaujon, Service de Gastroenterologie, Clichy , France; c University of Verona, Medicine and Surgery, General Surgery Section, MED/18 – General Surgery, Verona , Italy; d Uppsala University Hospital, Department of Radiology, Uppsala , Sweden; e Institut Català d’Oncologia, Barcelona , Spain; f Endokrinologie für Erwachsene, Inselspital, Bern , Switzerland; g Department of Internal Medicine, Section of Endocrinology, Erasmus MC, Rotterdam , The Netherlands; h Department of Endocrinology & Metabolism, Hadassah University Hospital, Jerusalem , Israel; i MHH, Klinik für Nuklearmedizin, Hannover , Germany; j Department of Surgery, C2122, Rigshospitalet Blegdamsvej, Copenhagen , Denmark; k Dana-Farber Cancer Institute, Boston, Mass. , USA; l Charité Universitätsmedizin, Department of Internal Medicine, Division of Hepatology and Gastroenterology, Campus Virchow Klinikum, Berlin , Germany